Researchers Report Success Reducing MS-like Disease in Mice
May 22, 2015
Researchers from the University of Montreal report that a molecule called "MCAM" helps immune cells to enter and attack the brain and spinal cord in mice with an MS-like disease. They found that blocking this molecule reduced disease activity in relapsing and progressive models of the disease. More study is needed to determine whether this blocking agent, now under development for psoriasis, has potential benefits for people with MS.
Read more on Medical News Today.
Read more about research in progressive MS.